As of 2024-12-11, the EV/EBITDA ratio of Ondine Biomedical Inc (OBI.L) is -2.31. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OBI.L's latest enterprise value is 31.84 mil GBP. OBI.L's TTM EBITDA according to its financial statements is -13.76 mil GBP. Dividing these 2 quantities gives us the above OBI.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 22.6x | 18.8x |
| Forward P/E multiples | 15.0x - 22.6x | 18.8x |
| Fair Price | (28.28) - (42.48) | (35.38) |
| Upside | -453.5% - -631.0% | -542.2% |
| Date | EV/EBITDA |
| 2024-12-05 | -4.04 |
| 2024-12-04 | -4.04 |
| 2024-12-03 | -4.04 |
| 2024-12-02 | -4.04 |
| 2024-11-29 | -4.04 |
| 2024-11-28 | -4.04 |
| 2024-11-27 | -4.17 |
| 2024-11-26 | -4.17 |
| 2024-11-25 | -4.24 |
| 2024-11-22 | -4.31 |
| 2024-11-21 | -4.24 |
| 2024-11-20 | -4.24 |
| 2024-11-19 | -4.24 |
| 2024-11-18 | -4.44 |
| 2024-11-15 | -4.31 |
| 2024-11-14 | -4.24 |
| 2024-11-13 | -4.17 |
| 2024-11-12 | -4.17 |
| 2024-11-11 | -4.31 |
| 2024-11-08 | -4.57 |
| 2024-11-07 | -4.57 |
| 2024-11-06 | -4.70 |
| 2024-11-05 | -4.57 |
| 2024-11-04 | -4.44 |
| 2024-11-01 | -4.57 |
| 2024-10-31 | -4.37 |
| 2024-10-30 | -4.17 |
| 2024-10-29 | -4.70 |
| 2024-10-28 | -4.70 |
| 2024-10-25 | -4.44 |
| 2024-10-24 | -3.84 |
| 2024-10-23 | -3.45 |
| 2024-10-22 | -3.45 |
| 2024-10-21 | -3.45 |
| 2024-10-18 | -3.45 |
| 2024-10-17 | -3.31 |
| 2024-10-16 | -3.31 |
| 2024-10-15 | -3.31 |
| 2024-10-14 | -3.11 |
| 2024-10-11 | -3.38 |
| 2024-10-10 | -3.38 |
| 2024-10-09 | -3.38 |
| 2024-10-08 | -3.31 |
| 2024-10-07 | -3.31 |
| 2024-10-04 | -3.31 |
| 2024-10-03 | -3.38 |
| 2024-10-02 | -3.51 |
| 2024-10-01 | -3.51 |
| 2024-09-30 | -3.58 |
| 2024-09-27 | -3.58 |